Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.

Abstract excerpt

Schizophrenia, which has both genetic and environmental causes, is associated with persistent symptoms and severe functional disability. The illness lies dormant during the premorbid phase and begins to express itself during adolescence or early adulthood. Clinical progression and deterioration reaches a plateau in which the patient is said to be in the chronic phase of illness and at which point restoration of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antipsychotic Agents
• Share to Atrophy
• Share to Chronic Disease